TY - JOUR
T1 - Mixed methods process evaluation of behavioural support and nicotine replacement therapy for smokeless tobacco cessation in Bangladesh, India, and Pakistan
AU - Siddiqui, Faraz
AU - Ahmad, Fayaz
AU - Fieroze, Fariza
AU - Mazhar, Laraib
AU - Nawaz, Anila Mahmood
AU - Iqbal, Romaina
AU - Rizvi, Narjis
AU - Kellar, Ian
AU - Khan, Javaid
AU - Siddiqi, Kamran
PY - 2026/1/8
Y1 - 2026/1/8
N2 - Introduction: Interventions for quitting smokeless tobacco are lacking in South Asia. In a pilot trial, we explored the feasibility of delivering and evaluating a culturally adapted behavioural intervention and/or nicotine replacement therapy in Bangladesh, India and Pakistan. This paper presents the process evaluation.Methods: Mixed methods consisted of interviews with 46 participants and five cessation advisors, a questionnaire completed by 236 trial participants, fidelity assessment of intervention delivery for 38 participants and intervention logs. Data were triangulated across three process evaluation functions (implementation, mechanisms of impact, context) and self-reported abstinence outcomes.
Results: After everyone attending the pre-quit behavioural session, attendance dropped to 86.3% (quit session) and 65.9% (>1 post-quit sessions). Abstainers attended more sessions. Advisors were confident in delivering the intervention, favouring face-to-face over remote, yet fidelity scores showed room for improvement. Attendance and fidelity scores were consistently best in Bangladesh. There was high acceptability and perceived usefulness of the behavioural intervention with an important role for the advisor especially among abstainers. Two-thirds perceived nicotine replacement therapy as useful, higher among abstainers. Taste and side effects were barriers; adherence was highest in India. Perceived drivers to cessation were new knowledge leading to positive attitudes, beliefs in capability to quit, and family support. Perceived barriers were nicotine addiction, social pressure and easy access to smokeless tobacco.Conclusions: This process evaluation affirms the feasibility and acceptability of implementing the BISCA and NRT interventions while identifying important areas for improvement prior to a full effectiveness trial.
AB - Introduction: Interventions for quitting smokeless tobacco are lacking in South Asia. In a pilot trial, we explored the feasibility of delivering and evaluating a culturally adapted behavioural intervention and/or nicotine replacement therapy in Bangladesh, India and Pakistan. This paper presents the process evaluation.Methods: Mixed methods consisted of interviews with 46 participants and five cessation advisors, a questionnaire completed by 236 trial participants, fidelity assessment of intervention delivery for 38 participants and intervention logs. Data were triangulated across three process evaluation functions (implementation, mechanisms of impact, context) and self-reported abstinence outcomes.
Results: After everyone attending the pre-quit behavioural session, attendance dropped to 86.3% (quit session) and 65.9% (>1 post-quit sessions). Abstainers attended more sessions. Advisors were confident in delivering the intervention, favouring face-to-face over remote, yet fidelity scores showed room for improvement. Attendance and fidelity scores were consistently best in Bangladesh. There was high acceptability and perceived usefulness of the behavioural intervention with an important role for the advisor especially among abstainers. Two-thirds perceived nicotine replacement therapy as useful, higher among abstainers. Taste and side effects were barriers; adherence was highest in India. Perceived drivers to cessation were new knowledge leading to positive attitudes, beliefs in capability to quit, and family support. Perceived barriers were nicotine addiction, social pressure and easy access to smokeless tobacco.Conclusions: This process evaluation affirms the feasibility and acceptability of implementing the BISCA and NRT interventions while identifying important areas for improvement prior to a full effectiveness trial.
U2 - 10.1093/ntr/ntag004
DO - 10.1093/ntr/ntag004
M3 - Article
SN - 1462-2203
JO - Nicotine and Tobacco Research
JF - Nicotine and Tobacco Research
ER -